[Pneumocystis and Staphylococcus aureus pulmonary co-infection after chemotherapy for lung cancer]

Med Mal Infect. 2011 Sep;41(9):497-9. doi: 10.1016/j.medmal.2011.02.008. Epub 2011 Apr 3.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / secondary
  • Carcinoma, Small Cell / complications
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / secondary
  • Ceftriaxone / administration & dosage
  • Ceftriaxone / therapeutic use
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cranial Irradiation
  • Etoposide / administration & dosage
  • Fatal Outcome
  • Female
  • Humans
  • Immunocompromised Host
  • Lung Neoplasms / complications
  • Lung Neoplasms / drug therapy*
  • Opportunistic Infections / complications*
  • Opportunistic Infections / drug therapy
  • Pneumonia, Pneumocystis / complications*
  • Pneumonia, Pneumocystis / drug therapy
  • Pneumonia, Staphylococcal / complications*
  • Pneumonia, Staphylococcal / drug therapy
  • Staphylococcus aureus
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Etoposide
  • Ceftriaxone
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Cisplatin